miR-582-5p Is Upregulated in Patients with Active Tuberculosis and Inhibits Apoptosis of Monocytes by Targeting FOXO1

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Liu, Yanhua ^a   Jiang, Jing ^a   Wang, Xinjing ^a   Zhai, Fei ^a   Cheng, Xiaoxing ^a  

^a 309TH HOSPITAL OF PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; MESSENGER RNA; MICRORNA; MICRORNA 582 5P; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; MIRN582 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; BACTERIAL IMMUNITY; BCG VACCINATION; BINDING SITE; CONTROLLED STUDY; EMBRYO; FEMALE; FOXO1 GENE; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; HUMAN; HUMAN CELL; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROTEIN EXPRESSION; UPREGULATION; CELL PROLIFERATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROCEDURES; TUBERCULOSIS;

3' UNTRANSLATED REGIONS; ADULT; APOPTOSIS; BINDING SITES; CELL PROLIFERATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; MICRORNAS; MONOCYTES; TRANSFECTION; TUBERCULOSIS; UP-REGULATION;

EID: 84886301150     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078381     Document Type: Article

References (29)

1. Glaziou P, Falzon D, Floyd K, Raviglione M, (2013) Global epidemiology of tuberculosis. Semin Respir Crit Care Med 34: 3-16.
2. Lawn SD, Zumla AI, (2011) Tuberculosis. Lancet 378: 57-72.
3. Schwander S, Dheda K, (2011) Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection. Am J Respir Crit Care Med 183: 696-707.
4. Philips JA, Ernst JD, (2012) Tuberculosis pathogenesis and immunity. Annu Rev Pathol 7: 353-384.
5. Rohde K, Yates RM, Purdy GE, Russell DG, (2007) Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev 219: 37-54.
6. Korbel DS, Schneider BE, Schaible UE, (2008) Innate immunity in tuberculosis: myths and truth. Microbes Infect 10: 995-1004.
7. Behar SM, Divangahi M, Remold HG, (2010) Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol 8: 668-674.
8. Chen M, Gan H, Remold HG, (2006) A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol 176: 3707-3716.
9. Divangahi M, Chen M, Gan H, Desjardins D, Hickman TT, et al. (2009) Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol 10: 899-906.
10. Gil DP, Leon LG, Correa LI, Maya JR, Paris SC, et al. (2004) Differential induction of apoptosis and necrosis in monocytes from patients with tuberculosis and healthy control subjects. J Infect Dis 189: 2120-2128.
11. Molloy A, Laochumroonvorapong P, Kaplan G, (1994) Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J Exp Med 180: 1499-1509.
12. Winau F, Weber S, Sad S, de Diego J, Hoops SL, et al. (2006) Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 24: 105-117.
13. Sanchez MD, Garcia Y, Montes C, Paris SC, Rojas M, et al. (2006) Functional and phenotypic changes in monocytes from patients with tuberculosis are reversed with treatment. Microbes Infect 8: 2492-2500.
14. O'Connell RM, Rao DS, Baltimore D, (2012) microRNA regulation of inflammatory responses. Annu Rev Immunol 30: 295-312.
15. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD, (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9: 839-845.
16. Liu Y, Wang X, Jiang J, Cao Z, Yang B, et al. (2011) Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. Mol Immunol 48: 1084-1090.
17. Winslow GM, Cooper A, Reiley W, Chatterjee M, Woodland DL, (2008) Early T-cell responses in tuberculosis immunity. Immunol Rev 225: 284-299.
18. Giordano S, Columbano A, (2013) MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 57: 840-847.
19. Aslam MI, Patel M, Singh B, Jameson JS, Pringle JH, (2012) MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application. J Transl Med 10: 128.
20. Abba M, Mudduluru G, Allgayer H, (2012) MicroRNAs in cancer: small molecules, big chances. Anticancer Agents Med Chem 12: 733-743.
21. Monsalve M, Olmos Y, (2011) The complex biology of FOXO. Curr Drug Targets 12: 1322-1350.
22. Wang W, Yan C, Zhang J, Lin R, Lin Q, et al. (2013) SIRT1 inhibits TNF-alpha-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1. Apoptosis 18: 689-701.
23. Wu Z, Sun H, Zeng W, He J, Mao X, (2012) Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS One 7: e45825.
24. Shen M, Lin F, Zhang J, Tang Y, Chen WK, et al. (2012) Involvement of the up-regulated FoxO1 expression in follicular granulosa cell apoptosis induced by oxidative stress. J Biol Chem 287: 25727-25740.
25. Xie L, Ushmorov A, Leithauser F, Guan H, Steidl C, et al. (2012) FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood 119: 3503-3511.
26. Huang H, Regan KM, Lou Z, Chen J, Tindall DJ, (2006) CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 314: 294-297.
27. Lu H, Liu P, Pan Y, Huang H, (2011) Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1. Neoplasia 13: 854-863.
28. Zhang H, Fang J, Yao D, Wu Y, Ip C, et al. (2010) Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells. Prostate 70: 1265-1273.
29. Berry E, Hardt JL, Clardy J, Lurain JR, Kim JJ, (2009) Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1. Gynecol Oncol 112: 331-336.